About Oboi Laboratories Pvt Ltd
Data last updated:
Oboi Laboratories Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1985PTC036765. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.5 Lakh. It is led by directors Keyur Ratanshi Shah and Kirti Talakshi Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Prabhat Nagar Jogeshwari(W) Bombay., Mumbai, Maharashtra, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹67,430, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹72,831 (net margin -108%) and EBITDA of -₹72,831 (EBITDA margin -108%). Revenue has declined at a compounded annual rate (CAGR) of 48% over three years and 29% over five years.
The company is associated with 1 brand: Oboi Laboratories.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oboilabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1 Prabhat Nagar Jogeshwari(W) Bombay., Mumbai, Maharashtra, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Oboi Laboratories Pvt Ltd FY 2025 filings available
Oboi Laboratories Pvt Ltd reported revenue of ₹67,430 (up 180% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Oboi Laboratories Pvt Ltd
Revenue rose 180% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 29%. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Oboi Laboratories Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹72,831 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹72,831 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Oboi Laboratories Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -108% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -108% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Oboi Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Oboi Laboratories Pvt Ltd
Oboi Laboratories Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wacky Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| Camerin Drugs and Pharmaceuticals Ltd | •••• | •••• | •••• | •••• | - | Cannanore, Kerala, India |
| Shatdal Pharma Private Limited | •••• | •••• | •••• | •••• | - | Nagpur, Maharashtra, India |
| Alexin Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Heartbit Pharma Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Oboi Laboratories Pvt Ltd this company | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Malik and Malik Pharma Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Toshi Biopharm Private Limited | •••• | •••• | •••• | •••• | - | Ashok Vihar Phase Iv, Delhi, India |
| Maze Medicare Private Limited | •••• | •••• | •••• | •••• | - | Rohtak, Haryana, India |
| Siddhaquest Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Abhinav Drug Chem Private Limited | •••• | •••• | •••• | •••• | - | Gujarat, India |
Peers are the five companies nearest above and the five nearest below Oboi Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Oboi Laboratories Pvt Ltd
Oboi Laboratories Pvt Ltd is audited by J C VAIDYA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J C VAIDYA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Oboi Laboratories Pvt Ltd
Oboi Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Keyur Ratanshi Shah Also directs: Acco Commercial LLP, Ciron Drugs and Pharmaceuticals Private Limited, Cho-Spn Lifescience and Research Private Limited and 1 more | Director | 21 Aug 2023 | 3 Years 1 Months | Current |
| Kirti Talakshi Shah | Director | 01 Nov 1995 | 30 Years 11 Months | Current |
Ownership and Shareholding of Oboi Laboratories Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Oboi Laboratories Pvt Ltd
Oboi Laboratories Pvt Ltd does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Oboi Laboratories Pvt Ltd
Oboi Laboratories operates one associated brand: Oboi Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures various dosage forms while providing contract manufacturing services. | oboilabs.com |
Employees and EPFO Compliance at Oboi Laboratories Pvt Ltd
Employment history and EPFO contributions of people linked to Oboi Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Oboi Laboratories Pvt Ltd
Oboi Laboratories Pvt Ltd has 5 board changes on record since 1995: 2 appointments and 3 cessations. The latest: Samir Ratanshi Shah ceased to be Director on 10 Jan 2025.
Credit Ratings, Litigation & Regulatory Alerts for Oboi Laboratories Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Oboi Laboratories Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Oboi Laboratories Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Oboi Laboratories Pvt Ltd
Oboi Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Oboi Laboratories Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oboi Laboratories Pvt Ltd
Oboi Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 1985 (41+ years old) and is registered under CIN U99999MH1985PTC036765.
Oboi Laboratories reported revenue of ₹67,430 for FY 2024 (up 180% YoY).
Oboi Laboratories has 2 current directors:
- Keyur Ratanshi Shah - Director
- Kirti Talakshi Shah - Director
Oboi Laboratories reported a net loss of ₹72,831 (net margin -108%) and EBITDA of -₹72,831 (EBITDA margin -108%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Oboi Laboratories is -48% over three years and -29% over five years. In the latest year (FY 2024) revenue rose 180%. CAGR is the steady yearly rate that links the first and the last year.
No. Oboi Laboratories has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Oboi Laboratories is U99999MH1985PTC036765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oboi Laboratories was incorporated on 08 July 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Oboi Laboratories by revenue are Wacky Healthcare Private Limited, Camerin Drugs and Pharmaceuticals Ltd, Shatdal Pharma Private Limited, Alexin Healthcare Private Limited, Heartbit Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Samir Ratanshi Shah ceased to be Director on 10 Jan 2025. Keyur Ratanshi Shah ceased to be Additional Director on 29 Sep 2023. Keyur Ratanshi Shah was appointed as Director on 21 Aug 2023. Oboi Laboratories has 5 board changes on record in total.
Oboi Laboratories can be reached through the website oboilabs.com. Its registered office is in Mumbai, Maharashtra, India.